Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)
Status:
Completed
Trial end date:
2002-08-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the long-term safety and tolerability of ezetimibe
(SCH 58235) 10 mg once daily or placebo in combination with atorvastatin (10 to 80 mg/day)
for up to 12 consecutive months in participants with primary hypercholesterolemia.